Baxter Introduces New Safety Management System and Software Updates for Sigma Spectrum Infusion System at ASHP Meeting
December 05 2016 - 8:30AM
Business Wire
- Software Provides Reports to Drive
Rapid Decisions and Quality Improvement Initiatives
- New Remote Professional Services
Include Quarterly Infusion Safety Monitoring Reports, Updated
Cybersecurity Reporting, Optional 24/7 Support
- System Has Initial Integration with
Omnicell® Performance Center Software to Enhance Pharmacy
Efficiency
Today at the American Society of Health-System Pharmacists
(ASHP) 2016 Midyear Meeting, Baxter International Inc. (NYSE: BAX)
announced the launch of the Sigma Spectrum Safety Management
System, which adds features designed to help minimize infusion
programming risks. The first is Baxter’s Infusion Analytics
application, a software solution that provides advanced infusion
data analysis and graphical reporting to help identify potential
pump programming errors. The second is a suite of Remote
Professional Services that offers 24/7 service and technical
support along with regular cybersecurity monitoring and
reporting.
“Baxter is committed to innovative technology for medication
delivery, and Baxter’s new Safety Management System further
reinforces Sigma Spectrum’s leadership helping hospitals
meet their infusion safety goals,” said David Ferguson, Global Head
of Baxter’s Fluid Systems franchise. “The new Infusion Analytics
application provides an enhanced user interface designed to make
infusion data easy to interpret, and new Remote Professional
Services add an additional level of technical support to help
protect data and maximize pump performance.”
These updates join existing Sigma Spectrum features
including the Master Drug Library (MDL) and Gateway. The MDL allows
users to create and customize a list of medications and fluids
within medically appropriate dose ranges to guide safe programming,
avoiding mistakes before they reach the patient. The Gateway is a
Web-based tool to publish drug libraries to the infusion pump fleet
and view Continuous Quality Improvement (CQI) data. Baxter is also
collaborating with Omnicell® to include an initial integration with
Omnicell’s Performance Center software, creating an efficient
workflow for the pharmacy to access and review both infusion and
medication data in one place.
Sigma Spectrum also includes features like integration
with electronic medical record (EMR) systems—including Cerner® and
Epic®—to help streamline clinical workflow and improve accuracy of
IV infusion documentation.
About Sigma Spectrum Infusion System
Sigma Spectrum’s hardware works in concert with the
pump’s software to encourage use of innovative features that are
designed to help enhance patient safety and clinician efficiency.
For example, the pumps automatically default to the installed drug
library without requiring clinicians to take extra steps to
“opt-in,” and drug library updates can be delivered wirelessly to
pumps in the facility without interrupting clinical workflow.
Sigma Spectrum is also the only pump to include a built-in
Dose/Rate Change Error Prevention Feature, which helps clinicians
protect high-risk infusions during titrations, and allows
pharmacists to customize dose change limits for individual drugs.
The Sigma Spectrum pump also includes built-in real-time
location tracking of equipment within a facility to protect against
misplacement, enhanced data analytics and use of standard IV set
technology that can yield up to 53 percent cost savings in IV
tubing sets and 30 percent reduction in IV tubing use.1
Rx Only. For the safe and proper use of this device,
refer to the appropriate operator’s manuals.
About Baxter
Baxter provides a broad portfolio of essential renal and
hospital products, including home, acute and in-center dialysis;
sterile IV solutions; infusion systems and devices; parenteral
nutrition; biosurgery products and anesthetics; and pharmacy
automation, software and services. The company’s global footprint
and the critical nature of its products and services play a key
role in expanding access to healthcare in emerging and developed
countries. Baxter’s employees worldwide are building upon the
company’s rich heritage of medical breakthroughs to advance the
next generation of healthcare innovations that enable patient
care.
Forward-Looking Statements
This release includes forward-looking statements concerning
Baxter's Sigma Spectrum Infusion Systems and related
performance data, including anticipated benefits associated with
its use. The statements are based on assumptions about many
important factors, including the following, which could cause
actual results to differ materially from those in the
forward-looking statements: satisfaction of regulatory and other
requirements; actions of regulatory bodies and other governmental
authorities; product quality, manufacturing or supply issues;
patient safety issues; breaches or failures of the company’s
information technology systems, changes in law and regulations; and
other risks identified in Baxter's most recent filing on Form 10-K
and other SEC filings, all of which are available on Baxter's
website. Baxter does not undertake to update its forward-looking
statements.
Baxter and Sigma Spectrum are trademarks of Baxter
International Inc.
Cerner is a registered trademark of Cerner Corporation and/or
its subsidiaries.
Epic is a registered trademark of Epic Systems Corporation in
the United States and/or in other countries.
Omnicell is a registered trademark of Omnicell, Inc. in the
United States and internationally.
1 Data on File. Baxter Healthcare Corporation. Total cost of
ownership standard set technology inventory and cost reduction data
2011- 2013. *Data provided by these facilities. Baxter makes no
guarantee of cost savings.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161205005677/en/
Baxter International Inc.Media ContactEric Tatro, (224)
948-5353media@baxter.comorInvestor ContactClare Trachtman,
(224) 948-3085
Baxter (NYSE:BAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Baxter (NYSE:BAX)
Historical Stock Chart
From Sep 2023 to Sep 2024